These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

646 related items for PubMed ID: 29846581

  • 1. Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates.
    Talbot JJ, Subedi S, Halliday CL, Hibbs DE, Lai F, Lopez-Ruiz FJ, Harper L, Park RF, Cuddy WS, Biswas C, Cooley L, Carter D, Sorrell TC, Barrs VR, Chen SC.
    J Antimicrob Chemother; 2018 Sep 01; 73(9):2347-2351. PubMed ID: 29846581
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Azole resistance and cyp51A mutation screening in Aspergillus fumigatus in Mexico.
    Gonzalez-Lara MF, Roman-Montes CM, Diaz-Lomeli P, Rangel-Cordero A, Valenzuela MO, Ponce-de-Leon A, Sifuentes-Osornio J, Ostrosky-Zeichner L, Martinez-Gamboa A.
    J Antimicrob Chemother; 2019 Jul 01; 74(7):2047-2050. PubMed ID: 31220262
    [Abstract] [Full Text] [Related]

  • 8. High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients.
    Fuhren J, Voskuil WS, Boel CH, Haas PJ, Hagen F, Meis JF, Kusters JG.
    J Antimicrob Chemother; 2015 Oct 01; 70(10):2894-8. PubMed ID: 26163402
    [Abstract] [Full Text] [Related]

  • 9. In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.
    Arendrup MC, Jensen RH, Cuenca-Estrella M.
    Antimicrob Agents Chemother; 2016 Jan 01; 60(1):532-6. PubMed ID: 26552973
    [Abstract] [Full Text] [Related]

  • 10. High prevalence of triazole resistance in clinical Aspergillus fumigatus isolates in a specialist cardiothoracic centre.
    Abdolrasouli A, Scourfield A, Rhodes J, Shah A, Elborn JS, Fisher MC, Schelenz S, Armstrong-James D.
    Int J Antimicrob Agents; 2018 Nov 01; 52(5):637-642. PubMed ID: 30103005
    [Abstract] [Full Text] [Related]

  • 11. Aspergillus fumigatus Clinical Isolates Carrying CYP51A with TR34/L98H/S297T/F495I Substitutions Detected after Four-Year Retrospective Azole Resistance Screening in Brazil.
    Pontes L, Beraquet CAG, Arai T, Pigolli GL, Lyra L, Watanabe A, Moretti ML, Schreiber AZ.
    Antimicrob Agents Chemother; 2020 Feb 21; 64(3):. PubMed ID: 31871090
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.
    Bueid A, Howard SJ, Moore CB, Richardson MD, Harrison E, Bowyer P, Denning DW.
    J Antimicrob Chemother; 2010 Oct 21; 65(10):2116-8. PubMed ID: 20729241
    [Abstract] [Full Text] [Related]

  • 14. Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.
    Alanio A, Sitterlé E, Liance M, Farrugia C, Foulet F, Botterel F, Hicheri Y, Cordonnier C, Costa JM, Bretagne S.
    J Antimicrob Chemother; 2011 Feb 21; 66(2):371-4. PubMed ID: 21131690
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Azole-resistant Aspergillus fumigatus in Denmark: a laboratory-based study on resistance mechanisms and genotypes.
    Jensen RH, Hagen F, Astvad KM, Tyron A, Meis JF, Arendrup MC.
    Clin Microbiol Infect; 2016 Jun 21; 22(6):570.e1-9. PubMed ID: 27091095
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Azole Resistance of Environmental and Clinical Aspergillus fumigatus Isolates from Switzerland.
    Riat A, Plojoux J, Gindro K, Schrenzel J, Sanglard D.
    Antimicrob Agents Chemother; 2018 Apr 21; 62(4):. PubMed ID: 29437612
    [Abstract] [Full Text] [Related]

  • 20. cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.
    Bader O, Weig M, Reichard U, Lugert R, Kuhns M, Christner M, Held J, Peter S, Schumacher U, Buchheidt D, Tintelnot K, Groß U, MykoLabNet-D Partners.
    Antimicrob Agents Chemother; 2013 Aug 21; 57(8):3513-7. PubMed ID: 23669382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.